Hepatic resection following selective internal radiation therapy for colorectal cancer metastases in the FOXFIRE clinical trial: clinical outcomes and distribution of microspheres
The FOXFIRE (5-Fluorouracil, OXaliplatin and Folinic acid ± Interventional Radio-Embolisation) clinical trial combined systemic chemotherapy (OxMdG: Oxaliplatin, 5-fluorouracil and folic acid) with Selective Internal Radiation Therapy (SIRT or radio-embolisation) using yttrium-90 resin micr...
المؤلفون الرئيسيون: | Winter, H, Rassam, J, Virdee, PS, Goldin, R, Pitcheshwar, P, Weaver, K, Primrose, J, Berry, DP, Wasan, HS, Sharma, RA |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
MDPI
2019
|
مواد مشابهة
-
Hepatic resection following selective internal radiotherapy in the FOXFIRE clinical trial: survival, safety, and histopathology
حسب: Virdee, PS, وآخرون
منشور في: (2018) -
Quality of life in the FOXFIRE, SIRFLOX, and FOXFIRE-Global randomised trials of selective internal radiotherapy for metastatic colorectal cancer
حسب: Wolstenholme, J, وآخرون
منشور في: (2019) -
FOXFIRE: a phase III clinical trial of chemo-radio-embolisation as first-line treatment of liver metastases in patients with colorectal cancer.
حسب: Sharma, R, وآخرون
منشور في: (2008) -
The FOXFIRE/SIRFLOX/FOXFIRE-Global randomised studies of first-line selective internal radiation therapy for metastatic colorectal cancer
حسب: Sharma, N, وآخرون
منشور في: (2017) -
FOXFIRE-SIRFLOX-FOXFIRE global prospective randomised studies of first-line selective internal radiotherapy (SIRT) in patients with liver metastases from colorectal cancer: KRAS mutation and tumour site analysis
حسب: Wasan, H, وآخرون
منشور في: (2017)